Eli Lilly’s diabetes drug Munjaro will be available in limited quantities until February 2024 due to increased demand, according to the US Food and Drug Administration. The health regulator’s website states that an injectable dose of 12.5 milligrams will be available in limited quantities while other doses of Munjaro are available.